Past public meetings relevant to consumer and health care antiseptics
| January 1997 NDAC Meeting (Joint meeting with the Anti-Infective Drug Advisory Committee) (January 6, 1997, 62 FR 764) (PDF - 20.28 MB) | Antiseptic and antibiotic resistance in relation to an industry proposal for consumer and health care antiseptic effectiveness testing (Health Care Continuum Model) |
| March 2005 NDAC Meeting (February 18, 2005, 70 FR 8376) | The use of surrogate endpoints and study design issues for in vivo testing of health care antiseptics |
| October 2005 NDAC Meeting (September 15, 2005, 70 FR 54560) | Benefits and risks of consumer antiseptics. NDAC expressed concern about the pervasive use of consumer antiseptic washes where there are potential risks and no demonstrable benefit. To demonstrate a clinical benefit, NDAC recommended clinical outcome studies to show that antiseptic washes are superior to non-antibacterial soap and water |
| November 2008 Public Feedback Meeting (PDF - 3.01 MB) (PDF - 137 KB) (PDF - 866 KB) | Demonstration of the effectiveness of consumer antiseptics |
| September 2014 NDAC Meeting (July 29, 2014, 79 FR 44042) | Safety testing framework for health care antiseptic active ingredients |